Recent Articles

May 25, 2017 10:12 am
Ryan Bushey
Overall, the drug was able to improve patients’ conditions and helped more individuals become seizure-free than placebo.
May 24, 2017 3:04 pm
Ryan Bushey
The trial is supported by the HIV Vaccines Trial Network (HVTN) and the National Institute of Allergy and Infectious Diseases (NIAID).
May 24, 2017 11:27 am
Joanne Van Zuidam
The Member States of World Health Organization (WHO) elected Tedros Adhanom Ghebreyesus, Ph.D., of Ethiopia as the new Director-General of WHO.
May 23, 2017 11:58 am
Joanne Van Zuidam
This is the sixth FDA approval for Actemra since it was launched in 2010—and the first drug approved to specifically treat patients with Giant Cell Arteritis.
May 22, 2017 11:16 am
Ryan Bushey
An experimental osteoporosis drug being developed by Amgen and UCB produced surprising safety data in this evaluation.
May 22, 2017 12:08 pm
Joanne Van Zuidam
Among patients with persistent hypercapnia (excess carbon dioxide in their blood) following a COPD exacerbation, the addition of a home ventilator device to oxygen therapy improves outcomes, according to new research presented at the 2017 American Thoracic Society International Conference.
May 19, 2017 11:59 am
Joanne Van Zuidam
The disease is endemic in approximately 60 countries and causes epidemics as well. It is estimated that cholera results in 2.9 million cases of disease and 95,000 deaths annually.
May 19, 2017 11:11 am
Ryan Bushey
Investigators gave 125 patients 150 or 300 mg subcutaneously administered dosages every four weeks or 300 mg every two weeks.
May 18, 2017 12:51 pm
Joanne Van Zuidam
Based on two clinical trials, the FDA has concluded that the type 2 diabetes drug canagliflozin, manufactured by Johnson & Johnson, causes an increased risk of leg and foot amputations.
May 17, 2017 10:40 am
Ryan Bushey
The healthcare giant’s pharmaceutical unit intends to launch or file for regulatory approval more than 10 novel therapies with blockbuster potential between 2017 and 2021.
Subscribe to Drug Discovery & Development